TrialInternational journal of hematology2011

Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial.

Yukari Shirasugi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.